Genotyping Market Size, Share, Growth Analysis, By Type(Microarray, Polymerase Chain Reaction (PCR), Sequencing, and Others), By Application(Pharmaceutical and Biopharmaceutical Companies, Diagnostic Laboratories and Clinics, Research Institutes and Academic Centers, and Others), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35D2088 | Region: Global | Published Date: April, 2024
Pages: 219 |Tables: 65 |Figures: 75

Genotyping Market Insights

Genotyping Market size was valued at USD 26.14 Billion in 2023 and is poised to grow from USD 31.89 Billion in 2024 to USD 156.54 Billion by 2032, growing at a CAGR of 22.0% during the forecast period (2025-2032).

The global genotyping market is experiencing robust growth fueled by advancements in genomics research, personalized medicine, and increasing demand for genetic testing.

The market is driven by factors such as the growing prevalence of genetic disorders, rising awareness about early disease diagnosis, and the development of precision medicine. Genotyping technologies, including microarrays, polymerase chain reaction (PCR), and next-generation sequencing (NGS), are widely used for genotyping applications in research and clinical settings.

Additionally, the integration of genotyping data with bioinformatics and data analytics tools is driving market growth. The market is highly competitive, with key players focusing on product innovation, expanding their genetic testing portfolios, and establishing strategic partnerships to capture a larger share in the global genotyping market.

US Genotyping Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 21.43 Billion

Largest Segment

Polymerase Chain Reaction (PCR)

Fastest Growth

Subsequent-Generation Sequencing (NGS)

Growth Rate

22.0% CAGR

Global Genotyping Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Genotyping Market Segmental Analysis

The Global Genotyping Market is segmented by type, application, and region. Based on type, the market can be segmented into microarray, polymerase chain reaction (pcr), sequencing, and others. Based on application, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic laboratories and clinics, research institutes and academic centers, and others.Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Analysis by Type

The type segment of the global genotyping market refers to the different methods or technologies used for genotyping analysis. This segment includes sub-segments such as microarray, polymerase chain reaction (pcr), sequencing, and others.

The dominant sub-segment in the type category is polymerase chain reaction (PCR). PCR is a widely used technique in genotyping that allows for the amplification and detection of specific DNA sequences. It is known for its accuracy, sensitivity, and ability to analyze a large number of samples in a short time. PCR-based genotyping has been extensively adopted in research, clinical diagnostics, and pharmaceutical development.

The fastest-growing sub-segment in the type category is sequencing. next-generation sequencing (NGS) technologies have revolutionized genotyping by enabling the analysis of entire genomes and providing a comprehensive view of genetic variations. NGS allows for high-throughput sequencing and has found applications in various fields, including research, clinical diagnostics, and personalized medicine. The decreasing cost of sequencing and the increasing demand for precision medicine and genomic research are driving the growth of the sequencing sub-segment.

Analysis by Application

The application segment of the global genotyping market refers to the various fields or areas where genotyping is applied. This segment includes sub-segments such as pharmaceutical and biopharmaceutical companies, diagnostic laboratories and clinics, research institutes and academic centers, and others.

The dominant sub-segment in the application category is pharmaceutical and biopharmaceutical companies. These companies utilize genotyping techniques for drug discovery, development, and personalized medicine. Genotyping helps in identifying genetic variations that may impact drug response, enabling the development of targeted therapies and improving patient outcomes. Pharmaceutical companies are increasingly incorporating genotyping into their research and development processes to support precision medicine approaches.

The fastest-growing sub-segment in the application category is research institutes and academic centers. Genotyping plays a crucial role in various research areas, including population genetics, disease genetics, and evolutionary biology. Research institutes and academic centers conduct extensive genotyping studies to understand the genetic basis of diseases, investigate genetic diversity, and discover new biomarkers. The growing emphasis on genomic research, advancements in technology, and collaborative efforts between academic and industry players are driving the growth of genotyping applications in this sub-segment.

Global Genotyping Market By Type

To get detailed analysis on other segments, Request For Free Sample Report

Genotyping Market Regional Insights

One dominant region in the global genotyping market is North America. The region has a well-established healthcare infrastructure, advanced research facilities, and a high adoption rate of genotyping technologies. North America is home to several major genotyping companies, research institutions, and academic centers, which contribute to its dominance in the market. The region's strong focus on genetic research, personalized medicine, and precision healthcare drives the demand for genotyping technologies.

One of the fastest-growing regions in the global genotyping market is Asia-Pacific. The region is witnessing rapid advancements in healthcare infrastructure, increasing investments in genomics research, and a growing demand for personalized medicine. Factors such as a large patient population, rising prevalence of genetic disorders, and government initiatives to promote genomics research contribute to the region's market growth. Additionally, the increasing awareness and adoption of genotyping technologies, coupled with a growing number of collaborations between academic institutions and industry players, are driving the growth of the genotyping market in the Asia-Pacific region.

Global Genotyping Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Genotyping Market Dynamics

Drivers

Increasing Prevalence Of Genetic Disorders And Personalized Medicine

  • One key driver of the global genotyping market is the increasing prevalence of genetic disorders and the growing demand for personalized medicine. Genotyping plays a crucial role in identifying genetic variations, mutations, and gene sequences that can be associated with specific diseases or drug responses. With advancements in genomic research and the understanding of genetic markers, genotyping enables personalized diagnosis, treatment, and drug selection. The rising prevalence of genetic disorders, coupled with the shift towards precision medicine approaches, drives the demand for genotyping technologies and services.

Restraints

Ethical And Privacy Concerns

  • One significant restraint in the global genotyping market is the ethical and privacy concerns associated with genetic testing. The access to an individual's genetic information raises concerns about the misuse or misinterpretation of such data. Questions around consent, data security, and the potential for discrimination based on genetic information pose challenges to the widespread adoption of genotyping. Moreover, the interpretation and communication of genetic test results to individuals and healthcare professionals require careful consideration to ensure accurate understanding and appropriate action. Addressing these ethical and privacy concerns is crucial to build trust, encourage participation, and promote the responsible use of genotyping technologies.

Request Free Customization of this report to help us to meet your business objectives.

Genotyping Market Competitive Landscape

The global Genotyping market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Genotypes. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.

Top Player’s Company Profiles

  • Agilent Technologies, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Danaher Corporation (United States)
  • PerkinElmer, Inc. (United States)
  • Fluidigm Corporation (United States)
  • Eurofins Scientific (Luxembourg)
  • Luminex Corporation (United States)
  • Pacific Biosciences of California, Inc. (United States)
  • Oxford Nanopore Technologies Ltd. (United Kingdom)
  • Affymetrix, Inc. (United States)
  • Genewiz (United States)
  • GENEWIZ Germany GmbH (Germany)
  • Bioline Reagents Ltd. (United Kingdom)
  • Genomic Health, Inc. (United States)
  • Takara Bio Inc. (Japan)
  • Agena Bioscience, Inc. (United States)

Recent Developments

  • In February 2024, Aquaculture biotechnology company Benchmark Holdings’ genetics division expanded its offerings with affordable genotyping tools and services. 
  • In November 2023, South Korea's GC Genome Corporation entered into a collaboration and exclusive license agreement with MP Group in Bangkok, Thailand, to commercialise 'Genome Health' for genetic health checkups. Genome Health, a SNP genotyping service, utilising next-generation sequencing (NGS) to identify risk alleles associated with major cancer types and general diseases, has been developed by GC Genome. 
  • In October 2023, Bruker Corporation announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for $108 million in cash.

Genotyping Key Market Trends

  • One key market trend in the global genotyping market is the increasing demand for personalized medicine and precision healthcare. Genotyping plays a crucial role in identifying genetic variations and markers associated with various diseases and drug responses. The advancements in genomic technologies and the decreasing cost of genotyping have made it more accessible for healthcare providers and researchers. Genotyping allows for tailored treatment plans based on an individual's genetic profile, leading to more targeted therapies, better disease management, and improved patient outcomes. This trend is driven by the growing understanding of the genetic basis of diseases and the potential for personalized interventions. Genotyping is revolutionizing healthcare by enabling more precise and effective interventions based on an individual's unique genetic makeup.

Genotyping Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

The global genotyping market is experiencing significant growth due to advancements in genomic research and personalized medicine. Genotyping plays a crucial role in understanding genetic variations and their impact on human health and disease. The market is driven by factors such as the increasing prevalence of genetic disorders, rising demand for precision medicine, and technological advancements in genotyping techniques. Key players in the market are focusing on developing innovative genotyping platforms and expanding their product portfolios to meet the growing demand. Additionally, the market is witnessing collaborations and partnerships between academic institutions, research organizations, and pharmaceutical companies to accelerate genotyping research and development. The market is expected to witness further growth with the increasing adoption of genotyping in areas like pharmacogenomics, agricultural research, and forensic sciences.

Report Metric Details
Market size value in 2022 USD 21.43 Billion
Market size value in 2031 USD 128.31 Billion
Growth Rate 22.0%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Microarray, Polymerase Chain Reaction (PCR), Sequencing, and Others
  • Application
    • Pharmaceutical and Biopharmaceutical Companies, Diagnostic Laboratories and Clinics, Research Institutes and Academic Centers, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Agilent Technologies, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Danaher Corporation (United States)
  • PerkinElmer, Inc. (United States)
  • Fluidigm Corporation (United States)
  • Eurofins Scientific (Luxembourg)
  • Luminex Corporation (United States)
  • Pacific Biosciences of California, Inc. (United States)
  • Oxford Nanopore Technologies Ltd. (United Kingdom)
  • Affymetrix, Inc. (United States)
  • Genewiz (United States)
  • GENEWIZ Germany GmbH (Germany)
  • Bioline Reagents Ltd. (United Kingdom)
  • Genomic Health, Inc. (United States)
  • Takara Bio Inc. (Japan)
  • Agena Bioscience, Inc. (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Genotyping Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Genotyping Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Genotyping Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Genotyping Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Genotyping Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Genotyping Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Genotyping Market size was valued at USD 21.43 Billion in 2022 and is poised to grow from USD 26.14 Billion in 2023 to USD 128.31 Billion by 2031, at a CAGR of 22.0% during the forecast period (2024-2031).

The global Genotyping market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Genotypes. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Thermo Fisher Scientific Inc. (United States)', 'Illumina, Inc. (United States)', 'QIAGEN N.V. (Netherlands)', 'Agilent Technologies, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Danaher Corporation (United States)', 'PerkinElmer, Inc. (United States)', 'Fluidigm Corporation (United States)', 'Eurofins Scientific (Luxembourg)', 'Luminex Corporation (United States)', 'Pacific Biosciences of California, Inc. (United States)', 'Oxford Nanopore Technologies Ltd. (United Kingdom)', 'Affymetrix, Inc. (United States)', 'Genewiz (United States)', 'GENEWIZ Germany GmbH (Germany)', 'Bioline Reagents Ltd. (United Kingdom)', 'Genomic Health, Inc. (United States)', 'Takara Bio Inc. (Japan)', 'Agena Bioscience, Inc. (United States)'

One key driver of the global genotyping market is the increasing prevalence of genetic disorders and the growing demand for personalized medicine. Genotyping plays a crucial role in identifying genetic variations, mutations, and gene sequences that can be associated with specific diseases or drug responses. With advancements in genomic research and the understanding of genetic markers, genotyping enables personalized diagnosis, treatment, and drug selection. The rising prevalence of genetic disorders, coupled with the shift towards precision medicine approaches, drives the demand for genotyping technologies and services.

One key market trend in the global genotyping market is the increasing demand for personalized medicine and precision healthcare. Genotyping plays a crucial role in identifying genetic variations and markers associated with various diseases and drug responses. The advancements in genomic technologies and the decreasing cost of genotyping have made it more accessible for healthcare providers and researchers. Genotyping allows for tailored treatment plans based on an individual's genetic profile, leading to more targeted therapies, better disease management, and improved patient outcomes. This trend is driven by the growing understanding of the genetic basis of diseases and the potential for personalized interventions. Genotyping is revolutionizing healthcare by enabling more precise and effective interventions based on an individual's unique genetic makeup.

One dominant region in the global genotyping market is North America. The region has a well-established healthcare infrastructure, advanced research facilities, and a high adoption rate of genotyping technologies. North America is home to several major genotyping companies, research institutions, and academic centers, which contribute to its dominance in the market. The region's strong focus on genetic research, personalized medicine, and precision healthcare drives the demand for genotyping technologies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Genotyping Market

Report ID: SQMIG35D2088

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE